Pharmafile

OCTOBER 6, 2023

India-based pharma company Sun Pharmaceutical Industries has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for deuruxolitinib for the treatment of adults with moderate to severe alopecia areata.

FDA 59

FDA 59

Pharmafile

SEPTEMBER 14, 2023

Sun Pharma has announced that one of its wholly owned subsidiaries has entered into a license agreement with Pharmazz in order to commercialise a first-in-class innovative drug, Tyvalzi (sovateltide) in India. The drug was developed by Pharmazz and is indicated for the treatment of cerebral ischemic stroke.

59

59

Pharmafile

MARCH 17, 2023

Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices. Sun Pharma and subsidiary, Taro Pharmaceutical, have agreed the settlement which will end their involvement in this case. read more

Documentation 97

Documentation 97

pharmaphorum

JANUARY 19, 2023

India’s Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss. Image courtesy of Abbassyma via Wikipedia The post Sun Pharma agrees deal to buy alopecia player Concert appeared first on.

Labelling 93

Labelling FDA Immunization 93

Pharmafile

FEBRUARY 13, 2023

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, from the US market. The drug is used for treating high blood pressure, angina and some types of irregular heartbeat. read more

FDA 115

FDA Communication 115

Drug Topics

MAY 14, 2024

Although sun protection is paramount, sunscreen options can be daunting. Warm weather means one thing: People are eager to be outdoors. How can pharmacists help?

211

211

Drug Topics

APRIL 12, 2023

A new survey found that neither generation is particularly good at maintaining healthy sun habits, and have low skin cancer awareness.

98

98

Pharmaceutical Technology

MARCH 29, 2024

Discover the innovative dermal patch system by Sun Pharmaceutical Industries Ltd for efficient and minimally invasive physiological sample collection. Patent US11877848B2 revolutionizes sample processing with a unique design.

52

52

Pharmaceutical Technology

JANUARY 18, 2024

Sun Pharma has signed a definitive merger agreement for the acquisition of all outstanding shares of Taro Pharmaceutical for $347.73m.

52

52

Drug Store News

JULY 6, 2023

CeraVe is joining forces with the New York Yankees and Chicago Cubs by sponsoring Sun Safety Day, taking place July 8 and July 22.

95

95

Fierce Pharma

JANUARY 19, 2023

Fierce Pharma Asia—China's reimbursement round; Sun's alopecia bet; GenScript's CDMO raise aliu Thu, 01/19/2023 - 15:53

107

107

Drug Store News

DECEMBER 26, 2023

Columbia Skincare announced a patented new formula of its talc-free antiseptic powders and a collection of sun care products.

52

52

Drug Store News

JANUARY 10, 2024

The Snowbird pack, crafted to bring sun-kissed vibes to adult consumers, is made with real vodka and juice.

52

52

Pharmaceutical Technology

JANUARY 19, 2023

Sun Pharmaceutical Industries has signed a definitive agreement to buy all outstanding shares of Concert Pharmaceuticals, in a deal valued at $576m. Sun Pharma stated that it will follow Concert’s plan to seek approval from the US Food and Drug Administration (FDA) for its new drug application in the first half of the year.

Labelling 59

Labelling FDA 59

Fierce Pharma

MAY 16, 2023

FDA orders Sun to hire manufacturing consultant for troubled plant as export pause persists fkansteiner Tue, 05/16/2023 - 09:33

FDA 88

FDA 88

Hospital Pharmacy Europe

SEPTEMBER 13, 2022

Sun awareness measures are not being followed by large numbers of European and non-Europeans increasing their risk of developing skin cancer. Perhaps of greater concern was how although 92% of Europeans were aware of the skin ageing risks posed by the sun, 84% admitted that they did not protect themselves all year round.

Hospitals 52

Hospitals 52

STAT

JANUARY 10, 2023

Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food and Drug Administration for a host of serious manufacturing violations at a key plant in India, the latest instance in which the company was tagged by the regulator for quality-control problems.

FDA 91

FDA 91

Fierce Pharma

MARCH 3, 2023

Sun Pharma suffers IT breach, says core systems not affected zbecker Fri, 03/03/2023 - 17:03

86

86

STAT

MAY 9, 2023

In a fresh sign of quality-control problems in the Indian pharmaceutical industry, the Food and Drug Administration decided that a Sun Pharmaceuticals facility failed to comply with a legal mandate to correct serious shortcomings. As a result, the company has halted exports from the plant to the United States.

FDA 79

FDA 79

Fierce Pharma

MARCH 14, 2023

In industrywide price-fixing case, Sun Pharma opts to settle for $75M fkansteiner Tue, 03/14/2023 - 10:12

89

89

Fierce Pharma

MAY 30, 2023

Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer kdunleavy Tue, 05/30/2023 - 09:57

81

81

Pharmaceutical Technology

MAY 30, 2023

Sun Pharmaceutical Industries has reached a licence agreement with Philogen for the commercialisation of Philogen’s Nidlegy (Daromun) in Australia, New Zealand and Europe. Sun Pharma has been granted exclusive commercialisation rights for Nidlegy in the three countries for the treatment of skin cancers.

52

52

Fierce Pharma

DECEMBER 20, 2022

Thea Pharma gets FDA nod for preservative-free rival to Sun and Viatris glaucoma eye drops. Tue, 12/20/2022 - 04:53.

FDA 92

FDA 92

Pharmaceutical Technology

SEPTEMBER 14, 2023

Pharmazz and Sun Pharma have signed a licence agreement for the marketing of Tyvalzi (Sovateltide) in India.

52

52

Pharmacy Times

JULY 27, 2022

With the vast number of drugs that can induce photosensitivity, patients taking any of these medications should receive safety counseling, especially during the summer months.

132

132

pharmaphorum

MAY 24, 2023

Here comes the sun – and AK too, if you’re not careful! Phil.Taylor Wed, 05/24/2023 - 08:32 Bookmark this

52

52

Fierce Pharma

MARCH 16, 2023

Fierce Pharma Asia—Sun's price-fixing settlement; Eisai's coverage win; AstraZeneca's India layoffs aliu Thu, 03/16/2023 - 14:52

52

52

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.

52

52

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.

52

52

PharmaShots

MAY 30, 2023

Nidlegy is being studied in the P-III trials for melanoma & non-melanoma skin cancers Ref: PR Newswire | Image: Sun Pharma Related News:- Sun Pharmaceutical’ Sezaby Receives the US FDA’s Approval for the Treatment of Neonatal Seizures PharmaShots! skin cancer.

FDA 40

FDA 40

Fierce Pharma

MAY 4, 2023

Fierce Pharma Asia—Astellas' eye drug buy; J&J's latest CAR-T deal; Sun's clinical hold aliu Thu, 05/04/2023 - 17:10

52

52

Drug Store News

FEBRUARY 8, 2024

One in five adults are unaware of the possibility of being sunburnt during the winter months, according to a new study by the American Academy of Dermatology.

115

115

Drug Topics

AUGUST 1, 2023

Be sure to vote in this month's poll!

98

98

STAT

DECEMBER 8, 2022

The sun is peeking through the clouds covering the Pharmalot campus, where the official mascot is chasing after various creatures and the coffee kettle is brewing yet another cup of stimulation. Top of the morning to you, and a fine one it is. Our choice today is chocolate raspberry. As always, you are invited to join us.

FDA 75

FDA 75

Drug Store News

AUGUST 9, 2023

In this month’s column, HRG’s Megan Moyer spotlights Andalou Naturals and its assortment of lotions featuring SPF.

97

97

PharmExec

JANUARY 18, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Drug Store News

NOVEMBER 15, 2023

Winlevi is the first and only topical androgen receptor inhibitor, and the newest Health Canada-approved formulation to target the hormonal component of acne in 40 years.

52

52